Cargando…
Walking the Line Between Antidonor and Antiviral Immunity: A Potential Role for Belatacept
Autores principales: | Gunasekaran, Deepthi, Pell, John, Menon, Madhav C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832058/ https://www.ncbi.nlm.nih.gov/pubmed/36644356 http://dx.doi.org/10.1016/j.ekir.2022.11.005 |
Ejemplares similares
-
Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016) -
Converting Maintenance Kidney-Transplant Patients From Belatacept to Another Immunosuppressive Regimen: A Cautionary Tale
por: Chandran, Sindhu, et al.
Publicado: (2020) -
Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
por: Ashokkumar, Chethan, et al.
Publicado: (2015) -
Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012) -
Belatacept: the challenges with transformational drugs
por: Vincenti, Flavio
Publicado: (2017)